AVKARE LLC: Drug Recall

Recall #D-0091-2023 · 12/22/2022

Class II: Risk

Recall Details

Recall Number
D-0091-2023
Classification
Class II
Product Type
Drug
Recalling Firm
AVKARE LLC
Status
Completed
Date Initiated
12/22/2022
Location
Pulaski, TN, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1237 cartons

Reason for Recall

Failed impurities/degradation specifications: Out of specification for unknown impurities.

Product Description

Glycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10) Unit Dose carton, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-363-15

Distribution Pattern

USA Nationwide

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.